Back
Santhera Pharmaceuticals Holding AG 10K Form
Sell
47
SPHDF
Santhera Pharmaceuticals Holding AG
Last Price:
$16.28
Seasonality Move:
11.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SPHDF News And Ratings
See the #1 stock for the next 7 days that we like better than SPHDF
SPHDF Financial Statistics
Sales & Book Value
| Annual Sales: | $44.4M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 3.49 |
| Annual Sales: | $4.57 |
| Price / Book: | 7.72 |
Profitability
| EPS (TTM): | -4.43000 |
|---|---|
| Net Income (TTM): | $-75.7M |
| Gross Margin: | $26M |
| Return on Equity: | 276.68% |
| Return on Assets: | 66.59% |
Santhera Pharmaceuticals Holding AG Earnings Forecast
Key Santhera Pharmaceuticals Holding AG Financial Ratios
-
The Gross Profit Margin over the past 18 years for SPHDF is 58.57%.
-
The Selling, General & Administrative Expenses for SPHDF have been equal to 77.97% of Gross Profit Margin.
-
The Research & Development expenses have been 67.66% of Revenue.
-
The Net Earning history of SPHDF is -107.30% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 10 years.
Santhera Pharmaceuticals Holding AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SPHDF |
| Website: | santhera.com |
Debt
| Debt-to-Equity Ratio: | 0.49 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.14 |
|---|---|
| Forward P/E Ratio: | 0 |
SPHDF Technical Analysis vs Fundamental Analysis
Sell
47
Santhera Pharmaceuticals Holding AG (SPHDF)
is a Sell
Is Santhera Pharmaceuticals Holding AG a Buy or a Sell?
-
Santhera Pharmaceuticals Holding AG stock is rated a SellThe current Santhera Pharmaceuticals Holding AG [SPHDF] share price is $16.28. The Score for SPHDF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.